Mangoceuticals (MGRX) Notes Payables (2022 - 2026)

Mangoceuticals has disclosed Notes Payables across 4 years of filings, most recently posting $44944.0 for Q2 2026.

• In Q2 2026, Notes Payables fell 91.01% year-over-year to $44944.0; the TTM figure through Jun 2026 stood at $44944.0 (down 91.01% YoY), while the FY2024 annual figure was $150000.0, changed N/A from the prior year.
• Notes Payables came in at $44944.0 for Q2 2026 at Mangoceuticals, down from $100000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $500000.0 in Q2 2025 to a low of $44944.0 in Q2 2026.
• Average Notes Payables over 4 years is $168330.5, with a median of $125000.0 recorded in 2024.
• Year-over-year, Notes Payables soared 166.67% in 2025 and sank 91.01% in 2026.
• Over 4 years, Notes Payables stood at $89200.0 in 2022, then surged by 68.16% to $150000.0 in 2024, then slumped by 33.33% to $100000.0 in 2025, then sank by 55.06% to $44944.0 in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $44944.0 in Q2 2026, $100000.0 in Q3 2025, and $500000.0 in Q2 2025.